CD63 and neoplasm: In a similar approach, Fang et al. recently developed a continuous-flow microfluidic system for the immunomagnetic capture of CD63( +) exosomes and detection of two exosomal tumour markers (EpCAM and HER2) in plasma samples using an immunofluorescence approach [48].